SEC 13F Intelligence

Managers / Q4 2023 · view latest →

BRIDGER MANAGEMENT, LLC

CIK 0001166309 · 90 PARK AVENUE, 40TH FLOOR, NEW YORK, NY, 10016 · 212-918-0820

Reported Value
$260M
Q4 2023
Positions
28
Filings on Record
37
2019–present window
Filed
Feb 14, 2024
original filing

Summary

Bridger Management, LLC reported $260M in U.S.-listed holdings across 28 positions for Q4 2023.

Its largest position, UBER, represents 10.6% of the portfolio.

Compared with Q3 2023, the fund opened 9 new positions and exited 12.

Portfolio Metrics

Turnover
+25.5%
vs prior filed quarter
Top-10 Concentration
+69.3%
share of reported value
Largest Position
+10.6%
Uber Technologies
New / Exited
9 / 12
positions this quarter

Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded, with multiple share classes and repeated sub-manager rows for the same issuer combined into one position — the same rule the holdings table uses by default. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.

Reported Value by Quarter

13F Reported Value
Q4 ’18: $1.2BQ4 ’18Q1 ’19: $1.3BQ2 ’19: $1.3BQ3 ’19: $1.2BQ4 ’19: $1.4BQ4 ’19Q1 ’20: $864MQ2 ’20: $1.1BQ3 ’20: $1.3BQ4 ’20: $1.3BQ4 ’20Q1 ’21: $1.1BQ2 ’21: $1.1BQ3 ’21: $855MQ4 ’21: $773MQ4 ’21Q1 ’22: $610MQ2 ’22: $444MQ3 ’22: $330MQ4 ’22: $247MQ4 ’22Q1 ’23: $268MQ2 ’23: $300MQ3 ’23: $272MQ4 ’23: $260MQ4 ’23Q1 ’24: $222MQ2 ’24: $194MQ3 ’24: $200MQ4 ’24: $186MQ4 ’24Q1 ’25: $201MQ2 ’25: $170MQ3 ’25: $186MQ4 ’25: $156MQ4 ’25Q1 ’26: $128Mfilingsflow.com

Portfolio Composition

By security type
Common Stock: 92.0%ADR: 6.8%Other: 1.2%Equity WRT: 0.0%
  • Common Stock · 92.0% · $239M
  • ADR · 6.8% · $18M
  • Other · 1.2% · $3M
  • Equity WRT · 0.0% · $9,053

Quarter-over-Quarter Changes full breakdown →

vs Q3 2023 (amended baseline)

IssuerMoveShare ΔShares nowValue ΔValue now
PFEPFIZER INCNEW+350.5K350.5K+$10M$10M
XENEXENON PHARMACEUTICALS INCNEW+146.8K146.8K+$7M$7M
SPRINGWORKS THERAPEUTICS INCNEW+101.1K101.1K+$4M$4M
ACADACADIA PHARMACEUTICALS INCNEW+117.3K117.3K+$4M$4M
ALNYALNYLAM PHARMACEUTICALS INCNEW+18.9K18.9K+$4M$4M
ATRCATRICURE INCNEW+87.1K87.1K+$3M$3M
CN2CATALYST PHARMACEUTICALS INCNEW+184.5K184.5K+$3M$3M
CYTKCYTOKINETICS INCNEW+22.5K22.5K+$2M$2M

Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.

Holdings — Q4 2023

28 positions
Export to Excel
#IssuerClass% PortfolioValue ↓Shares
1UBERUBER TECHNOLOGIES INChistory →COM10.56%$27M445.4K
2GDDYGODADDY INChistory →CL A9.66%$25M236.2K
3CZRCAESARS ENTERTAINMENT INC NEhistory →COM7.73%$20M427.9K
4VRTXVERTEX PHARMACEUTICALS INChistory →COM7.52%$20M48.0K
5MSMORGAN STANLEYhistory →COM NEW6.54%$17M181.9K
6LLYELI LILLY & COhistory →COM6.31%$16M28.1K
7TEVATEVA PHARMACEUTICAL INDS LTDhistory →SPONSORED ADS6.03%$16M1.50M
8BBWIBATH & BODY WORKS INChistory →COM5.53%$14M332.3K
9USFDUS FOODS HLDG CORPhistory →COM5.46%$14M312.3K
10ENDEAVOR GROUP HLDGS INCCL A COM3.99%$10M436.9K
11CHTRCHARTER COMMUNICATIONS INC Nhistory →CL A3.97%$10M26.5K
12PFEPFIZER INChistory →COM3.89%$10M350.5K
13DCBODOCEBO INChistory →COM3.60%$9M192.9K
14CCKCROWN HLDGS INChistory →COM3.51%$9M99.0K
15XENEXENON PHARMACEUTICALS INChistory →COM2.61%$7M146.8K
16QTRXQUANTERIX CORPhistory →COM1.63%$4M154.9K
17SPRINGWORKS THERAPEUTICS INCCOM1.42%$4M101.1K
18ACADACADIA PHARMACEUTICALS INChistory →COM1.42%$4M117.3K
19ALNYALNYLAM PHARMACEUTICALS INChistory →COM1.40%$4M18.9K
20WILLIAMS ROWLAND ACQUISITIONCOM1.20%$3M297.0K
21ATRCATRICURE INChistory →COM1.20%$3M87.1K
22CN2CATALYST PHARMACEUTICALS INChistory →COM1.20%$3M184.5K
23QUREUNIQURE NVSHS0.95%$2M362.3K
24GOOGLALPHABET INCCAP STK CL A0.75%$2M13.9K
25MLCOMELCO RESORTS AND ENTMNT LTDADR0.73%$2M214.8K
26CYTKCYTOKINETICS INCCOM NEW0.72%$2M22.5K
27MSFTMICROSOFT CORPCOM0.47%$1M3.3K
28SRZNWSURROZEN INC*W EXP 08/01/2030.00%$9,053466.7K

Filing History

QuarterReported ValuePositionsFiledTypeLinks
Q1 2026$128M24May 15, 202613F-HRchanges · EDGAR ↗
Q4 2025$156M24Feb 17, 202613F-HRchanges · EDGAR ↗
Q3 2025$186M28Nov 14, 202513F-HRchanges · EDGAR ↗
Q2 2025$170M25Aug 11, 202513F-HRchanges · EDGAR ↗
Q1 2025$201M29May 15, 202513F-HRchanges · EDGAR ↗
Q4 2024$186M28Feb 14, 202513F-HRchanges · EDGAR ↗
Q3 2024$200M29Nov 14, 202413F-HRchanges · EDGAR ↗
Q2 2024$194M28Aug 14, 202413F-HRchanges · EDGAR ↗
Q1 2024$222M31May 15, 202413F-HRchanges · EDGAR ↗
Q4 2023$260M28Feb 14, 202413F-HRchanges · EDGAR ↗
Q3 2023$272M31Nov 14, 202313F-HRchanges · EDGAR ↗
Q2 2023$300M29Aug 14, 202313F-HRchanges · EDGAR ↗
Q1 2023$268M28May 15, 202313F-HRchanges · EDGAR ↗
Q4 2022$247M23Feb 15, 202313F-HRchanges · EDGAR ↗
Q3 2022$330M44Nov 14, 202213F-HRchanges · EDGAR ↗
Q2 2022$444M43Aug 15, 202213F-HRchanges · EDGAR ↗
Q1 2022$610M52May 13, 202213F-HRchanges · EDGAR ↗
Q4 2021$773M44Feb 14, 202213F-HRchanges · EDGAR ↗
Q3 2021$855M46Nov 15, 202113F-HRchanges · EDGAR ↗
Q2 2021$1.1B44Aug 16, 202113F-HRchanges · EDGAR ↗
Q1 2021$1.1B42May 14, 202113F-HRchanges · EDGAR ↗
Q4 2020$1.3B39Feb 16, 202113F-HRchanges · EDGAR ↗
Q3 2020$1.3B36Nov 16, 202013F-HRchanges · EDGAR ↗
Q2 2020$1.1B35Aug 14, 202013F-HRchanges · EDGAR ↗
Q1 2020$864M36May 15, 202013F-HRchanges · EDGAR ↗
Q4 2019$1.4B35Feb 14, 202013F-HRchanges · EDGAR ↗
Q3 2019$1.2B30Nov 14, 201913F-HRchanges · EDGAR ↗
Q2 2019$1.3B31Aug 14, 201913F-HRchanges · EDGAR ↗
Q1 2019$1.3B33May 15, 201913F-HRchanges · EDGAR ↗
Q4 2018$1.2B34Feb 14, 201913F-HRchanges · EDGAR ↗

13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.